Pizarra, Mercedes D.
HRN: 25-35-13 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2026
CEFTRIAXONE 1G (VIAL)
01/17/2026
01/24/2026
IV
2g
OD
Acute Pyelonephritis
Checking Initial Appropriateness
01/18/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/18/2026
01/18/2026
IV
4.5g
Now
Complicated UTI
Checking Initial Appropriateness
01/18/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/18/2026
01/24/2026
IV
2.25g
Q6h
Complicated UTI
Checking Initial Appropriateness